Essex Investment Management’s Augmedix, Inc. Common Stock AUGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-528,985
Closed -$2.16M 332
2024
Q1
$2.16M Buy
528,985
+125,457
+31% +$561K 0.43% 96
2023
Q4
$2.36M Sell
403,528
-30,758
-7% -$162K 0.46% 78
2023
Q3
$2.24M Buy
+434,286
New +$2.04M 0.37% 90

Other funds holding AUGX

Essex Investment Management's AUGX Position: Q2 2024 in Review

Essex Investment Management sold out of Augmedix, Inc. Common Stock (AUGX) in Q2 2024, closing a stake of 528,985 shares — an estimated $2.16M sold.

Essex Investment Management first reported a position in AUGX in Q3 2023 and held it in 3 quarters. The position peaked at $2.36M in Q4 2023. 52 funds tracked by Wall St. Rank hold AUGX as of Q2 2024.

  • Essex Investment Management reported no remaining Augmedix, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Essex Investment Management sold 528,985 Augmedix, Inc. Common Stock shares in Q2 2024, an estimated $2.16M.
  • Essex Investment Management first reported a position in Augmedix, Inc. Common Stock in Q3 2023 and held it in 3 quarters.
  • Essex Investment Management's Augmedix, Inc. Common Stock position peaked at $2.36M in Q4 2023.
  • 52 funds tracked by Wall St. Rank held Augmedix, Inc. Common Stock as of Q2 2024.

Based on Essex Investment Management's 13F filing for Q2 2024, filed 12 Aug 2024.